News

Date

Title

08 Mar 2021
Mainstay Medical Announces Commercial Launch of ReActiv8 in Australia
16 Feb 2021
Mainstay Medical Announces US$108 Million Equity Financing Transaction
25 Jan 2021
Mainstay Medical Announces Key Strategic Hires to Drive Global Commercial Expansion
22 Jun 2020
Mainstay Medical Announces U.S. FDA Approval of ReActiv8® Neurostimulation System for Chronic Low Back Pain
15 Feb 2018
Mainstay Releases 2017 Annual Report

24 Jun 2014

Mainstay Medical featured as Showcase Technology Company at the Tech Tour and International Venture Club’s HEALTHTECH Summit 2014.
14 Oct 2012

Mainstay Medical Limited Awarded Neurotech’s Golden Electrode Award for Most Promising Startup